Expanding Client Capabilities from First-in-Human Through Registration

The combination of Caidya and Simbec-Orion gives clients access to broader expertise, geographic reach, and support across the clinical development lifecycle. In this discussion, the leaders highlight complementary capabilities in medical and regulatory strategy, clinical operations, data management, biostatistics, and early-phase development. Simbec-Orion’s clinical pharmacology capabilities add first-in-human, healthy volunteer, and early patient studies, while Caidya expands access across the United States, China, and the wider Asia-Pacific region. Together, Caidya and Simbec-Orion can support sponsors from first-in-human studies through Phase II, Phase III, and registrational trials within a more connected global development model.